STAT+: Weight-loss startup Calibrate cuts 18% of workforce as obesity drugs spark growing competition
The layoffs come as more digital health providers aim to offer access to new, highly-effective obesity medications such as Novo Nordisk’s Wegovy.
Calibrate, a telehealth company that prescribes obesity drugs and provides weight loss coaching, cut 18% of its workforce amid growing competition from digital medicine companies.
The company will focus more on partnering with employers to provide services to their workers, the company said in a statement. “Calibrate is accelerating our transformation into an Enterprise-first business, shifting internal resources and restructuring our team,” the company said. Still, “we will continue to grow our direct-to-consumer business responsibly.”
What's Your Reaction?
